Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Life Sciences

Life Sciences firms use Gerson Lehrman Group (GLG) to help seize opportunities more quickly and confidently by tapping the power of the world's marketplace for expertise.

Current clients:

GLG currently serves nearly 40 of the world's leading Life Sciences firms. These firms use our services in all Life Sciences segments, including pharmaceuticals, biotechnology, and medical devices. Within our Life Sciences clients, we most typically serve the corporate development, strategy, marketing, and business development functions.

How GLG helps:

Using GLG's unique model, Life Sciences clients receive fast-turnaround, high-quality, cost-effective, custom, and proprietary written reports. Clients also use our service to obtain telephone consultations, in-person meetings, seminars, and travel programs. We particularly excel at projects that address focused, tough issues faced by senior executives.

  • Corporate Development, M&A, and Licensing Executives — These executives use GLG throughout their process, from better triage of new opportunities, to faster assessment of acquisitions, to more objective diligence of specific acquisition targets and licensing opportunities. The GLG network can quickly and confidentially assess the assumptions behind management teams' presentations and investment bankers' offering memoranda. GLG assembles robust panels of experts around target technologies and companies, including key opinion leaders (KOLs), customers, former executives, former regulators, niche consultants, and academics familiar with key compounds or economic issues. Panels are assembled within days; custom reports are delivered within weeks.
  • Strategy & Marketing Executives — Marketing and strategy professionals use GLG to gain granular, customized, "beyond-the-headlines" reports on rapidly evolving markets. Subject-matter experts in the network comment on the technological, economic, regulatory, and behavioral trends in the most obscure parts of the value chain and the most obscure regions in the world. Strategy experts in the GLG network interview these experts and deliver cost-effective, custom reports within weeks.
  • Business Development Executives — Business development executives know that the worst thing that they can do is waste their targets' time. Too many sales executives prepare for pitches and prepare account strategies with imperfect information about the actual business issues facing their target clients. To address this problem, GLG provides highly-targeted education services to help sales professionals understand the individual accounts and executives they are pitching. Primarily by telephone, GLG clients speak with niche industry consultants, specialized academics, trade journalists, former executives, customers, and resellers in their target's industries.

Unique advantages:

Gerson Lehrman Group helps Life Sciences executives find, engage and manage ongoing relationships with experts, including many KOLs, all within a carefully structured and rules-based environment.

Find:

  • GLG's 250+ Research Professionals in client service and expert recruiting use proprietary tools to identify, contact, and evangelize the benefits of the GLG Councils to thousands of professionals from around the world each month. Life Sciences executives with urgent requirements can request accelerated recruiting of particular populations or individuals.
  • GLG systematically solicits information from GLG Council Members about their backgrounds and experience to help clients avoid conflicts of interest and manage disclosures other compliance concerns.
  • Once enrolled in the GLG CouncilsSM, experts are categorized within unique taxonomies, with dynamic questionnaires canvassing their experience with and knowledge of niche subjects. This continuous profiling helps GLG clients access targeted experts, even on short notice.
  • GLG's proprietary GLG CouncilRankSM algorithm ranks Council Members based upon objective data. By enabling over ten thousand consulting transactions each month, GLG has rich data on the demonstrated value of experts.

Engage:

  • Life Sciences firms do not have time to manage contracts and negotiate consulting fees for dozens of independent experts and consulting firms. GLG signs all Council Members up to industry -standard contracting. Pre-set consulting rates and integrated payment procedures reduce strain on clients' finance departments.
  • Life Sciences executives also vary widely on how they want to engage professionals. While licensing executives may desire a series of phone consultations, strategy executives may need a custom written report, and product development executives may need a fast-turnaround buyer survey. Executives use all these tools and others (including in-person meetings, seminars, and travel programs) to tap the expertise within in the GLG Councils.

Manage:

  • GLG provides easy-to-use Web-based software for Life Sciences employees to share, comment upon, and search the expert contacts acquired. This eliminates the need to update personal address books and immediately improves communication between colleagues, while enabling them to build their lists of contacts as enterprise-wide assets.
  • Compliance staff can easily block, screen, or monitor consultations using GLG's unique Oversight Dashboard technology.
  • For accounting staff seeking to allocate research costs to specific individuals, ideas, and P&Ls, GLG provides tools to track usage and manage spending.

Contact us to learn more about Gerson Lehrman Group solutions for Life Sciences

Request information on GLG solutions for your firm

GLG Life Sciences Customer Advisory Board

The GLG Life Sciences Customer Advisory Board is a forum for senior executives of innovative Life Sciences firms to discuss how external expertise drives decision-making within the industry.

GLG Life Sciences CAB
English, 70KB Adobe PDF

GLG Research StudySM

245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.

GLG Research Study: 245 Neurologists on Tysabri for MS